Brief: Tscan Therapeutics Presents Initial Phase 1 Clinical Results On Tsc-100 And Tsc-101
09/12/2023 23:58
Dec 9 (Reuters) - TScan Therapeutics Inc TCRX.O :
* TSCAN THERAPEUTICS PRESENTS INITIAL PHASE 1 CLINICAL
RESULTS ON
TSC-100 AND TSC-101 AT THE 65TH AMERICAN SOCIETY OF HEMATOLOGY
ANNUAL MEETING AND EXPOSITION
Source text for Eikon: ID:nGNX6cMt7k
Further company coverage: TCRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tscan Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Broadcom, Deere & Co, Snowflake
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp
U.S. STOCKS ON THE MOVE-AEVEX, Sirius XM, PG&E
U.S. STOCKS ON THE MOVE-TScan Therapeutics, EOS Energy, Brown-Forman Corp
Brief: TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics - SEC Filing